Danielle M. Brander

Oncology

20 Duke Medicine Cir
Durham, NC 27710

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancy.

Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancy.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: April 16, 2026

Second Primary Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Comprehensive Review.

Second Primary Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Comprehensive Review.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 06, 2026

Refitting fitness in CLL.

Refitting fitness in CLL.

Journal: Blood

Published: November 13, 2025

An indirect comparison of zanubrutinib vs acalabrutinib plus venetoclax in patients with treatment-naive CLL.

An indirect comparison of zanubrutinib vs acalabrutinib plus venetoclax in patients with treatment-naive CLL.

Journal: Blood advances

Published: October 29, 2025

Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia.

Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia.

Journal: HemaSphere

Published: June 06, 2025

Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy.

Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy.

Journal: Transplantation and cellular therapy

Published: May 30, 2025

Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.

Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.

Journal: American journal of hematology

Published: May 07, 2025

Back from (BTKi) holiday.

Back from (BTKi) holiday.

Journal: Blood advances

Published: January 14, 2025

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Journal: Blood cancer journal

Published: January 10, 2025

Statistical Perspectives and Meta-Analytic Approaches in Surrogate End Point Evaluation for Chronic Lymphocytic Leukemia.

Statistical Perspectives and Meta-Analytic Approaches in Surrogate End Point Evaluation for Chronic Lymphocytic Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 12, 2024

Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA.

Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 08, 2024

Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry.

Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry.

Journal: Blood cancer journal

Published: September 24, 2024

Showing 1-12 of 76

Last Updated: 09/26/2026